LPA - lipoprotein(a) Gene

Species: Macaca fascicularis

Gene Type: protein coding
Gene ID: 101865897

LPA Products (4)

mRNA Protein Name
XM_045391714.1 XP_045247649.1 apolipoprotein(a) isoform X3
XM_045391715.1 XP_045247650.1 apolipoprotein(a) isoform X4
XM_045391712.1 XP_045247647.1 apolipoprotein(a) isoform X1
XM_045391713.1 XP_045247648.1 apolipoprotein(a) isoform X2
Protein Preferred Names Protein Names

apolipoprotein(a)

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Bioactive Molecules (4)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-10341 Fasudil Hydrochloride 99.97% Yes
HY-10341A Fasudil 99.98% Yes
HY-10341C Fasudil dihydrochloride 99.98% Yes
HY-10341B Fasudil hydrochloride semihydrate / Unkown

Clinical Phase

Bioactive Molecules (8)
Cat. No. Product Name Effect
Purity Phase
HY-139853 BMS-986278 Antagonist 99.95% Phase 3
HY-152857 Muvalaplin Inhibitor 99.96% Phase 3
HY-153492A Olpasiran sodium Inhibitor 98.82% Phase 3
HY-177640 Lepodisiran Inhibitor 91.95% Phase 3
HY-177640A Lepodisiran sodium Inhibitor / Phase 3
HY-100619 BMS-986020 Antagonist 99.83% Phase 2
HY-120797 CRT0273750 98.87% Phase 2
HY-145561 Cudetaxestat Inhibitor 98.32% Phase 2
Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P991310 Lpathomab Inhibitor / Phase 1

Pre-clinical Phase

Bioactive Molecules (106)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-107614 1-Oleoyl lysophosphatidic acid sodium Inducer 99.96% Unkown
HY-137862 1-Oleoyl lysophosphatidic acid Activator 99.96% Unkown
HY-13285 Ki16425 99.30% Unkown
HY-132222 SET2 Antagonist 99.78% Unkown
HY-16040 AM095 free acid Inhibitor 99.02% Unkown
HY-15277 AM966 Antagonist 98.91% Unkown
HY-16039 AM095 Antagonist 99.72% Unkown
HY-107616 H2L5186303 98.50% Unkown
HY-114379 AS2717638 Antagonist 99.85% Unkown
HY-117779 DBIBB 98.07% Unkown
HY-15706 H2L 5765834 Antagonist 98.66% Unkown
HY-145344 ONO-8430506 Inhibitor 99.90% Unkown
HY-150204 ONO-0740556 Agonist 99.78% Unkown
HY-107501 (Rac)-1-Oleoyl lysophosphatidic acid sodium 98.0% Unkown
HY-100619A BMS-986020 sodium Inhibitor 99.88% Yes
HY-124772 BI-2545 Inhibitor 98.85% Unkown
HY-107615 TC LPA5 4 Antagonist 99.69% Unkown
HY-18075 LPA2 antagonist 1 Inhibitor 98.63% Unkown
HY-117444 ONO-9780307 Inhibitor 99.94% Unkown
HY-120967 (2S)-OMPT triethylamine, in ethanol:chloroform (1:1), 98% 99.0% Unkown
HY-W127502 1-Hexadecyl lysophosphatidic acid 99.89% Unkown
HY-117959 TAK-615 Inhibitor 98.07% Unkown
HY-100676 GRI977143 99.29% Unkown
HY-114380 Radioprotectin-1 Agonist 99.49% Unkown
HY-138453 ACT-1016-0707 Antagonist 98.28% Unkown
HY-100882 ONO-7300243 Antagonist 98.11% Unkown
HY-120478 ASP6432 Antagonist 99.92% Unkown
HY-175646 AGPAT4-IN-1 99.04% Unkown
HY-18641 Ki16198 Antagonist 98.17% Unkown
HY-116100A HA155 Inhibitor 98.50% Unkown
HY-151391 LPA5 antagonist 1 98.91% Unkown
HY-18076 LPA1 receptor antagonist 1 Antagonist 99.13% Unkown
HY-128127 NAEPA Agonist ≥99.0% Unkown
HY-115450 ONO-0300302 Antagonist 98.02% Unkown
HY-103267 S32826 disodium Inhibitor 98.85% Unkown
HY-124072 HL001 98.90% Unkown
HY-124535 TGX-115 Inhibitor 99.31% Unkown
HY-146945S Arachidonoyl LPA-d5 95% Unkown
HY-146956S Oleoyl LPA-d5 98.0% Unkown
HY-157693 C18:1 Cyclic LPA 99% Unkown
HY-W923661 1-Octadecyl lysophosphatidic acid Activator 95% Unkown
HY-113973 LPA2 antagonist 2 Antagonist 95.0% Unkown
HY-120967A (2S)-OMPT / Unkown
HY-139061 Palmitoyl 3-carbacyclic phosphatidic acid Inhibitor 99.9% Unkown
HY-145486 1-Arachidonoyl-sn-glycerol 3-phosphate ammonium / Unkown
HY-146955S Linoleoyl LPA-d5 95% Unkown
HY-151392 LPA5 antagonist 2 Antagonist 99.62% Unkown
HY-167862A UCM-05194 ammonium Agonist / Unkown
HY-167862 UCM-05194 90.0% Unkown
HY-184076 Ibrilparant / Unkown
HY-184986 PIPE-791 / Unkown
HY-103267A S32826 Inhibitor / Unkown
HY-107614G 1-Oleoyl lysophosphatidic acid sodium (GMP) Activator / Unkown
HY-118539 NSC12404 Agonist / Unkown
HY-119013 VPC32183 / Unkown
HY-119601 GRI918013 Inhibitor / Unkown
HY-123522 PAT-048 Inhibitor / Unkown
HY-126230 PAT-494 / Unkown
HY-126230A (Rac)-PAT-494 / Unkown
HY-126233A PAT-347 sodium Inhibitor / Unkown
HY-129808 VPC12249 Antagonist / Unkown
HY-130011 CCG-232964 Inhibitor / Unkown
HY-137862A (Rac)-1-Oleoyl lysophosphatidic acid Control / Unkown
HY-148291 BrP-LPA sodium / Unkown
HY-157617 16:0 Cyclic LPA ammonium / Unkown
HY-157669 1-Oleoyl-sn-glycero-2,3-cyclic-phosphate ammonium / Unkown
HY-160616 LPA5 antagonist 3 Antagonist / Unkown
HY-171464A Lp(a)-IN-5 hydrochloride Inhibitor 99.70% Unkown
HY-171465 Lp(a)-IN-6 / Unkown
HY-171806 BMT-136088 Ligand / Unkown
HY-171906A 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium Inhibitor / Unkown
HY-173322 Lp(a)-IN-8 Inhibitor / Unkown
HY-173323 Lp(a)-IN-7 Inhibitor / Unkown
HY-173324 LPA2 antagonist 5 Antagonist / Unkown
HY-173325 LPA2 antagonist 6 Antagonist / Unkown
HY-173509 ATX inhibitor 27 Inhibitor / Unkown
HY-174267S ATX-IN-2 Inhibitor / Unkown
HY-175084 1-Hexadecyl lysophosphatidic acid sodium Activator / Unkown
HY-177640C FAM labled Lepodisiran sodium Inhibitor / Unkown
HY-177640D Cy3 labled Lepodisiran sodium Inhibitor / Unkown
HY-178845 Decyl phosphate Modulator / Unkown
HY-179580 EL244 99.55% Unkown
HY-181452 1-Arachidoyl-2-hydroxy-sn-glycero-3-PA sodium / Unkown
HY-182787 LPA1 receptor antagonist-7 Antagonist / Unkown
HY-404647 FK3453 Inhibitor 99.98% Unkown
HY-N15794 AzoLPA ammonium Activator / Unkown
HY-N15931 18:1 1,3-Cyclic LPA ammonium / Unkown
HY-N16000 12:0 Biotinyl LPA ammonium / Unkown
HY-RS07745 LPA Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-W040175 L-NASPA ammonium Inhibitor / Unkown
HY-W040176 N-PTyrosine PA ammonium Modulator / Unkown
HY-W725737 BrP-LPA / Unkown
HY-W783254 C18 LPA / Unkown
HY-10341D Fasudil mesylate / Unkown
HY-139133 L-NASPA Inhibitor / Unkown
HY-160003 PPARγ agonist 9 Agonist / Unkown
HY-160173 LPA receptor antagonist-1 Antagonist / Unkown
HY-167201 2ccPA Inhibitor / Unkown
HY-171464 Lp(a)-IN-5 Inhibitor / Unkown
HY-171906 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA Inhibitor / Unkown
HY-172566 1-Myristyl-2-hydroxy-sn-glycero-3-PA Activator / Unkown
HY-181456 1-Octadecyl-2-hydroxy-sn-glycero-3-phosphate sodium / Unkown
HY-185932 Tisbesiran Inhibitor / Unkown
HY-N16077 C16 Cyclic LPA ammonium / Unkown
HY-N16110 17:0 Cyclic LPA ammonium / Unkown
HY-W725317 C16 LPA ammonium / Unkown
Inhibitory Antibodies (1)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P992262 Anti-LPA/Lysophosphatidic acid Antibody (504B3) / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens LPA NCBI NCBI:4018